{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:57:04Z","timestamp":1788195424132,"version":"build-2803163510"},"reference-count":88,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"G. Magnotta Foundation for Vector-Borne Diseases"},{"name":"The McCain Foundation"},{"name":"Rotary Woodstock NB"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Lyme disease, caused by vector-borne <jats:italic>Borrelia<\/jats:italic> bacteria, can present with diverse multi-system symptoms that resemble other conditions. The objective of this study was to evaluate disease presentations and <jats:italic>Borrelia<\/jats:italic> seroreactivity in individuals experiencing a spectrum of chronic and complex illnesses. We recruited 157 participants from Eastern Canada who reported one or more diagnoses of Lyme disease, neurological, rheumatic, autoimmune, inflammatory, gastrointestinal, or cardiovascular illnesses, or were asymptomatic and presumed healthy. Intake categories were used to classify participants based on their perceived proximity to Lyme disease, distinguishing between those with a disclosed history of <jats:italic>Borrelia<\/jats:italic> infection, those with lookalike conditions (e.g. fibromyalgia syndrome), and those with unrelated ailments (e.g. intestinal polyps). Participants completed three questionnaires, the SF-36 v1, SIQR, and HMQ, to capture symptoms and functional burden, and provided blood serum for analysis at an accredited diagnostic lab. Two-tiered IgG and IgM serological assessments (whole cell ELISA and Western blot) were performed in a blinded fashion on all samples. The pattern of symptoms and functional burden were similarly profound in the presumptive Lyme and Lyme-like disease categories. <jats:italic>Borrelia<\/jats:italic> seroprevalence across the study cohort was 10% for each of IgG and IgM, and occurred within and beyond the Lyme disease intake category. Western blot positivity in the absence of reactive ELISA was also substantial. Fibromyalgia was the most common individual diagnostic tag disclosed by two-tier IgG-positive participants who did not report a history of Lyme disease. Within the IgG seropositive cohort, the presence of antibodies against the 31 kDa Outer Surface Protein A (OspA) was associated with significantly better health outcomes. Previously, this marker has been linked to treatment-refractory Lyme arthritis. Overall, our findings support prior observations of phenotypic overlap between Lyme and other diseases. Seropositivity associated with non-specific symptoms and functional impairment warrants further mechanistic investigation and therapeutic optimization.<\/jats:p>","DOI":"10.1371\/journal.pone.0291382","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T18:38:37Z","timestamp":1699468717000},"page":"e0291382","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Profiling disease burden and Borrelia seroprevalence in Canadians with complex and chronic illness"],"prefix":"10.1371","volume":"18","author":[{"given":"Victoria P.","family":"Sanderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3686-1991","authenticated-orcid":true,"given":"Vladimir V.","family":"Bamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manali","family":"Tilak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vett K.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3326-6118","authenticated-orcid":true,"given":"Gurpreet","family":"Singh-Ranger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7448-8657","authenticated-orcid":true,"given":"Melanie K. B.","family":"Wills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"key":"pone.0291382.ref001","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.cll.2015.08.004","article-title":"Clinical Manifestations and Treatment of Lyme Disease","volume":"35","author":"JL Sanchez","year":"2015","journal-title":"Clin Lab Med"},{"key":"pone.0291382.ref002","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/pathogens8040299","article-title":"Lyme Disease Frontiers: Reconciling Borrelia Biology and Clinical Conundrums","volume":"8","author":"V. Bamm V","year":"2019","journal-title":"Pathogens"},{"key":"pone.0291382.ref003","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40257-014-0108-2","article-title":"Lyme Disease Update for the General Dermatologist","volume":"16","author":"DA Godar","year":"2015","journal-title":"Am J Clin Dermatol"},{"key":"pone.0291382.ref004","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1542\/peds.96.6.1053","article-title":"Neurologic manifestations in children with Lyme disease","volume":"96","author":"PM Bingham","year":"1995","journal-title":"Pediatrics"},{"key":"pone.0291382.ref005","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJM200306123482423","article-title":"The presenting manifestations of Lyme disease and the outcomes of treatment","volume":"348","author":"AC Steere","year":"2003","journal-title":"N Engl J Med"},{"key":"pone.0291382.ref006","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/pch\/20.7.377","article-title":"Clinical characteristics, treatment and outcome of children with Lyme arthritis in Nova Scotia","volume":"20","author":"PD Glaude","year":"2015","journal-title":"Paediatr Child Heal"},{"key":"pone.0291382.ref007","doi-asserted-by":"crossref","first-page":"e0168613","DOI":"10.1371\/journal.pone.0168613","article-title":"The Accuracy of Diagnostic Tests for Lyme Disease in Humans, A Systematic Review and Meta-Analysis of North American Research","volume":"11","author":"LA Waddell","year":"2016","journal-title":"PLoS One"},{"key":"pone.0291382.ref008","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fmed.2017.00224","article-title":"The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome","volume":"4","author":"AW Rebman","year":"2017","journal-title":"Front Med"},{"key":"pone.0291382.ref009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2020.560018","article-title":"Risk Factors and Outcomes of Treatment Delays in Lyme Disease: A Population-Based Retrospective Cohort Study","volume":"7","author":"AG Hirsch","year":"2020","journal-title":"Front Med"},{"key":"pone.0291382.ref010","first-page":"1","article-title":"Recent Progress in Lyme Disease and Remaining Challenges","volume":"8","author":"JR Bobe","year":"2021","journal-title":"Front Med"},{"key":"pone.0291382.ref011","doi-asserted-by":"crossref","first-page":"194","DOI":"10.14745\/ccdr.v43i10a01","article-title":"Surveillance for Lyme disease in Canada: 2009\u20132015","volume":"43","author":"S Gasmi","year":"2017","journal-title":"Canada Commun Dis Rep"},{"key":"pone.0291382.ref012","first-page":"11","article-title":"Lyme disease in children: Data from the Canadian Paediatric Surveillance Program","author":"NH Ogden","year":"2020","journal-title":"Ticks Tick Borne Dis"},{"issue":"6","key":"pone.0291382.ref013","doi-asserted-by":"crossref","first-page":"S1482","DOI":"10.1093\/clinids\/11.Supplement_6.S1482","article-title":"Neurologic manifestations of Lyme disease, the new \u201cgreat imitator\u201d","volume":"11","author":"AR Pachner","year":"1989","journal-title":"Rev Infect Dis"},{"key":"pone.0291382.ref014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3844\/ajidsp.2018.1.44","article-title":"Chronic Lyme Disease: A Working Case Definition","volume":"14","author":"RB Stricker","year":"2018","journal-title":"Am J Infect Dis"},{"key":"pone.0291382.ref015","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.parkreldis.2015.05.015","article-title":"The association between infectious burden and Parkinson\u2019s disease: A case-control study","volume":"21","author":"X-L Bu","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"pone.0291382.ref016","first-page":"7","article-title":"Historic evidence to support a causal relationship between spirochetal infections and Alzheimer\u2019s disease","author":"J. Miklossy","year":"2015","journal-title":"Front Aging Neurosci"},{"key":"pone.0291382.ref017","first-page":"13","article-title":"Lyme Borreliosis as a Trigger for Autoimmune Disease","author":"Y Yehudina","year":"2021","journal-title":"Cureus"},{"key":"pone.0291382.ref018","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000008144","article-title":"Chronic Fatigue Syndrome in Patients with Lyme Borreliosis","volume":"43","author":"J Treib","year":"2000","journal-title":"Eur Neurol"},{"key":"pone.0291382.ref019","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-117-4-281","article-title":"Lyme disease associated with fibromyalgia","volume":"117","author":"H Dinerman","year":"1992","journal-title":"Ann Intern Med"},{"key":"pone.0291382.ref020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-12-173","article-title":"Probable late lyme disease: a variant manifestation of untreated Borrelia burgdorferi infection","volume":"12","author":"JN Aucott","year":"2012","journal-title":"BMC Infect Dis"},{"key":"pone.0291382.ref021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics8040269","article-title":"Chronic lyme disease: An evidence\u2010based definition by the ILADS working group","volume":"8","author":"S Shor","year":"2019","journal-title":"Antibiotics"},{"key":"pone.0291382.ref022","article-title":"Mistaken Identity: Many Diagnoses are Frequently Misattributed to Lyme Disease","author":"T Kobayashi","year":"2022","journal-title":"Am J Med"},{"key":"pone.0291382.ref023","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"K Bjornevik","year":"2022","journal-title":"Science (80-)"},{"key":"pone.0291382.ref024","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41590-021-01104-y","article-title":"Pathological sequelae of long-haul COVID","volume":"23","author":"S Mehandru","year":"2022","journal-title":"Nat Immunol"},{"key":"pone.0291382.ref025","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0140-6736(21)00446-3","article-title":"Long-haul COVID: heed the lessons from other infection-triggered illnesses","volume":"397","author":"JN Aucott","year":"2021","journal-title":"Lancet"},{"key":"pone.0291382.ref026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar2830","article-title":"The revised fibromyalgia impact questionnaire (FIQR): Validation and psychometric properties","volume":"11","author":"RM Bennett","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"pone.0291382.ref027","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00296-008-0722-5","article-title":"Fibromyalgia subgroups: Profiling distinct subgroups using the Fibromyalgia Impact Questionnaire. A preliminary study","volume":"29","author":"JB De Souza","year":"2009","journal-title":"Rheumatol Int"},{"key":"pone.0291382.ref028","first-page":"265","article-title":"Canadian normative data for the SF-36 health survey","volume":"163","author":"WM Hopman","year":"2000","journal-title":"Cmaj"},{"key":"pone.0291382.ref029","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hec.4730020305","article-title":"The rand 36\u2010item health survey 1.0","volume":"2","author":"RD Hays","year":"1993","journal-title":"Health Econ"},{"key":"pone.0291382.ref030","unstructured":"Ware JEJE, Kosinski M, Keller SDSD. SF-36 Physical and Mental Health Summary Scales: A User\u2019s Manual. A user\u2019s manual. 1994. pp. 1\u2013147. Available: https:\/\/www.researchgate.net\/profile\/John_Ware\/publication\/292390260_SF-36_Physical_and_Mental_Health_Summary_Scales_a_User\u2019s_Manual\/links\/5af580264585157136caee31\/SF-36-Physical-and-Mental-Health-Summary-Scales-a-Users-Manual.pdf"},{"key":"pone.0291382.ref031","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-7525-5-54","article-title":"Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.1","volume":"5","author":"SS Farivar","year":"2007","journal-title":"Health Qual Life Outcomes"},{"key":"pone.0291382.ref032","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/IJGM.S140224","article-title":"Empirical validation of the Horowitz Multiple Systemic Infectious Disease Syndrome Questionnaire for suspected Lyme disease","volume":"10","author":"M Citera","year":"2017","journal-title":"Int J Gen Med"},{"key":"pone.0291382.ref033","first-page":"14","article-title":"Understanding and using factor scores: Considerations for the applied researcher","author":"C DiStefano","year":"2009","journal-title":"Pract Assessment, Res Eval"},{"key":"pone.0291382.ref034","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1128\/jcm.33.2.419-427.1995","article-title":"Immunoblot interpretation criteria for serodiagnosis of early Lyme disease","volume":"33","author":"SM Engstrom","year":"1995","journal-title":"J Clin Microbiol"},{"key":"pone.0291382.ref035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1079\/9781845938048.0073","article-title":"Laboratory diagnostic testing for Borrelia burgdorferi infection","author":"BJB Johnson","year":"2011","journal-title":"Lyme Dis An Evidence-Based Approach"},{"key":"pone.0291382.ref036","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1128\/iai.60.8.3033-3041.1992","article-title":"Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi- infected mice","volume":"60","author":"L Yang","year":"1992","journal-title":"Infect Immun"},{"key":"pone.0291382.ref037","article-title":"Infectious BNRJ of, 1993. Western blotting in the serodiagnosis of Lyme disease","author":"F Dressler","year":"1993","journal-title":"J Infect Dis"},{"key":"pone.0291382.ref038","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/JCM.00874-16","article-title":"Lyme borreliosis serology: Performance of several commonly used laboratory diagnostic tests and a large resource panel of well-characterized patient samples","volume":"54","author":"CR Molins","year":"2016","journal-title":"J Clin Microbiol"},{"key":"pone.0291382.ref039","author":"W. Revelle","year":"2023"},{"key":"pone.0291382.ref040","first-page":"253","article-title":"FactoMineR: An R Package for Multivariate Analysis","volume":"25","author":"S L\u00ea","year":"2008","journal-title":"J Stat Softw"},{"key":"pone.0291382.ref041","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1529-0131(199902)12:1<42::AID-ART7>3.0.CO;2-3","article-title":"The Fibromyalgia Impact Questionnaire: a useful tool in evaluating patients with post-Lyme disease syndrome","volume":"12","author":"J Fallon","year":"1999","journal-title":"Arthritis Care Res"},{"key":"pone.0291382.ref042","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/cid\/cix943","article-title":"Advances in Serodiagnostic Testing for Lyme Disease Are at Hand","volume":"66","author":"JA Branda","year":"2017","journal-title":"Clin Infect Dis"},{"key":"pone.0291382.ref043","doi-asserted-by":"crossref","first-page":"s259","DOI":"10.1093\/cid\/ciq117","article-title":"Relationship between Immunity to Borrelia burgdorferi Outer-surface Protein A (OspA) and Lyme Arthritis","volume":"52","author":"AC Steere","year":"2011","journal-title":"Clin Infect Dis"},{"key":"pone.0291382.ref044","article-title":"Illness perceptions, coping, and health-related quality of life among individuals experiencing chronic Lyme disease","author":"EM Hill","year":"2020","journal-title":"Chronic Illn"},{"key":"pone.0291382.ref045","first-page":"1","article-title":"Experiences of patients identifying with chronic Lyme disease in the healthcare system: A qualitative study","volume":"15","author":"A Ali","year":"2014","journal-title":"BMC Fam Pract"},{"key":"pone.0291382.ref046","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.7717\/peerj.322","article-title":"Severity of chronic Lyme disease compared to other chronic conditions: a quality of life survey","volume":"2","author":"L Johnson","year":"2014","journal-title":"PeerJ"},{"key":"pone.0291382.ref047","first-page":"9","article-title":"Persistent Anti- Borrelia IgM Antibodies without Lyme Borreliosis in the Clinical and Immunological Context","author":"M Markowicz","year":"2021","journal-title":"Microbiol Spectr"},{"key":"pone.0291382.ref048","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1128\/JCM.01409-14","article-title":"Collection and characterization of samples for establishment of a serum repository for lyme disease diagnostic test development and evaluation","volume":"52","author":"CR Molins","year":"2014","journal-title":"J Clin Microbiol"},{"key":"pone.0291382.ref049","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3201\/eid1805.111366","article-title":"Bartonella spp. Bacteremia and rheumatic symptoms in patients from Lyme disease-endemic region","volume":"18","author":"RG Maggi","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"pone.0291382.ref050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pathogens11020203","article-title":"Cross-Reactive Results in Serological Tests for Borreliosis in Patients with Active Viral Infections","volume":"11","author":"I Wojciechowska-Koszko","year":"2022","journal-title":"Pathogens"},{"key":"pone.0291382.ref051","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/096120339500400209","article-title":"False positive seroreactivity to Borrelia burgdorferi in systemic lupus erythematosus: The value of immunoblot analysis","volume":"4","author":"NL Weiss","year":"1995","journal-title":"Lupus"},{"key":"pone.0291382.ref052","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1099\/0022-1317-51-9-731","article-title":"Recombinant OspC from Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii in the serodiagnosis of Lyme borreliosis","volume":"51","author":"J Panelius","year":"2002","journal-title":"J Med Microbiol"},{"key":"pone.0291382.ref053","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1128\/jcm.28.6.1276-1279.1990","article-title":"Cross-reactivity of nonspecific treponemal antibody in serologic tests for Lyme disease","volume":"28","author":"LA Magnarelli","year":"1990","journal-title":"J Clin Microbiol"},{"key":"pone.0291382.ref054","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/infdis\/156.1.183","article-title":"Cross-Reactivity in Serological Tests for Lyme Disease and Other Spirochetal Infections","volume":"156","author":"LA Magnarelli","year":"1987","journal-title":"J Infect Dis"},{"key":"pone.0291382.ref055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0262229","article-title":"Borrelia burgdorferi and Borrelia miyamotoi in Atlantic Canadian wildlife","volume":"17","author":"CB Zinck","year":"2022","journal-title":"PLoS One"},{"key":"pone.0291382.ref056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2020.567350","article-title":"Borrelia miyamotoi Serology in a Clinical Population With Persistent Symptoms and Suspected Tick-Borne Illness","volume":"7","author":"SL Delaney","year":"2020","journal-title":"Front Med"},{"key":"pone.0291382.ref057","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.3390\/pathogens10101284","article-title":"Monitoring risk: Tick and borrelia burgdorferi public participatory surveillance in the Canadian maritimes, 2012\u20132020","volume":"10","author":"J Lewis","year":"2021","journal-title":"Pathogens"},{"key":"pone.0291382.ref058","first-page":"527","article-title":"Seroprevalence of Borrelia burgdorferi, Anaplasma phagocytophilum, Ehrlichia canis, and Dirofilaria immitis among dogs in Canada","volume":"52","author":"A Villeneuve","year":"2011","journal-title":"Can Vet J"},{"key":"pone.0291382.ref059","first-page":"981","article-title":"Lyme disease risk in dogs in New Brunswick","volume":"57","author":"NK Bjurman","year":"2016","journal-title":"Can Vet J = La Rev Vet Can"},{"key":"pone.0291382.ref060","doi-asserted-by":"crossref","first-page":"208","DOI":"10.14745\/ccdr.v48i05a04","article-title":"Surveillance for Ixodes scapularis and Ixodes pacificus ticks and their associated pathogens in Canada, 2019","volume":"48","author":"C Wilson","year":"2022","journal-title":"Canada Commun Dis Rep"},{"key":"pone.0291382.ref061","unstructured":"Public health Agency of Canada. Lyme Disease Surveillance Report: Preliminary Annual Edition 2019. 2022; 1\u201311."},{"key":"pone.0291382.ref062","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3201\/eid2110.141640","article-title":"Epidemiology of Lyme Disease, Nova Scotia, Canada, 2002\u20132013","volume":"21","author":"TF Hatchette","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"pone.0291382.ref063","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3201\/eid2504.180202","article-title":"Seroprevalence of borrelia burgdorferi, B. Miyamotoi, and Powassan virus in residents bitten by Ixodes ticks, Maine, USA","volume":"25","author":"RP Smith","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"pone.0291382.ref064","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3201\/eid2007.131587","article-title":"Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the northeastern United States","volume":"20","author":"PJ Krause","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"pone.0291382.ref065","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/healthcare6040125","article-title":"Under-Detection of Lyme Disease in Canada","volume":"6","author":"V Lloyd","year":"2018","journal-title":"Healthcare"},{"key":"pone.0291382.ref066","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/cid\/ciu703","article-title":"A Comparison of Lyme Disease Serologic Test Results From 4 Laboratories in Patients With Persistent Symptoms After Antibiotic Treatment","volume":"59","author":"BA Fallon","year":"2014","journal-title":"Clin Infect Dis"},{"key":"pone.0291382.ref067","doi-asserted-by":"crossref","first-page":"e0171731","DOI":"10.1371\/journal.pone.0171731","article-title":"Antibody responses to Borrelia burgdorferi detected by western blot vary geographically in Canada. Bergstr\u00f6m S, editor","volume":"12","author":"NH Ogden","year":"2017","journal-title":"PLoS One"},{"key":"pone.0291382.ref068","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jpids\/piy133","article-title":"Two-tier lyme disease serology test results can vary according to the specific first-tier test used","volume":"9","author":"AB Maulden","year":"2020","journal-title":"J Pediatric Infect Dis Soc"},{"key":"pone.0291382.ref069","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.diagmicrobio.2012.09.003","article-title":"Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease","volume":"75","author":"GP Wormser","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"pone.0291382.ref070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-28908-7","article-title":"Whole genome sequencing and phylogenetic analysis of strains of the agent of Lyme disease Borrelia burgdorferi from Canadian emergence zones","volume":"8","author":"S Tyler","year":"2018","journal-title":"Sci Rep"},{"key":"pone.0291382.ref071","doi-asserted-by":"crossref","first-page":"115572","DOI":"10.1016\/j.diagmicrobio.2021.115572","article-title":"A brief history of OspA vaccines including their impact on diagnostic testing for Lyme disease","volume":"102","author":"GP Wormser","year":"2022","journal-title":"Diagn Microbiol Infect Dis"},{"key":"pone.0291382.ref072","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1128\/IAI.00189-06","article-title":"Serologic proteome analysis of Borrelia burgdorferi membrane-associated proteins","volume":"74","author":"AJ Nowalk","year":"2006","journal-title":"Infect Immun"},{"key":"pone.0291382.ref073","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/infdis\/jit269","article-title":"Tick-specific borrelial antigens appear to be upregulated in American but not European patients with lyme arthritis, a late manifestation of lyme borreliosis","volume":"208","author":"X Li","year":"2013","journal-title":"J Infect Dis"},{"key":"pone.0291382.ref074","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/CVI.00002-11","article-title":"Anti-Borrelia burgdorferi antibody profile in post-lyme disease syndrome","volume":"18","author":"A Chandra","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"pone.0291382.ref075","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciaa1215","article-title":"Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease","volume":"72","author":"PM Lantos","year":"2021","journal-title":"Clin Infect Dis"},{"key":"pone.0291382.ref076","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/infdis\/167.1.158","article-title":"Characterization of the Borreliacidal Antibody Response to Borrelia burgdorferi in Humans: A Serodiagnostic Test","volume":"167","author":"SM Callister","year":"1993","journal-title":"J Infect Dis"},{"key":"pone.0291382.ref077","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/infdis\/169.3.568","article-title":"Sera from patients with chronic lyme disease protect mice from lyme borreliosis","volume":"169","author":"E Fikrig","year":"1994","journal-title":"J Infect Dis"},{"key":"pone.0291382.ref078","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1016\/j.vaccine.2017.04.079","article-title":"Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development","volume":"35","author":"JR Izac","year":"2017","journal-title":"Vaccine"},{"key":"pone.0291382.ref079","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s12016-015-8509-4","article-title":"Fibromyalgia: A Critical and Comprehensive Review","volume":"49","author":"AT Borchers","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"pone.0291382.ref080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.24095\/hpcdp.35.1.02","article-title":"Chronic fatigue syndrome and fibromyalgia in Canada: prevalence and associations with six health status indicators","volume":"35","author":"C Rusu","year":"2015","journal-title":"Heal Promot chronic Dis Prev Canada"},{"key":"pone.0291382.ref081","doi-asserted-by":"crossref","first-page":"44S","DOI":"10.1016\/S0002-9343(99)80043-6","article-title":"Musculoskeletal manifestations of Lyme disease","volume":"98","author":"AC Steere","year":"1995","journal-title":"Am J Med"},{"key":"pone.0291382.ref082","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/art.1780361103","article-title":"\u201cChronic lyme disease\u201d as the incorrect diagnosis in patients with fibromyalgia","volume":"36","author":"VM Hsu","year":"1993","journal-title":"Arthritis Rheum"},{"key":"pone.0291382.ref083","doi-asserted-by":"crossref","first-page":"503","DOI":"10.7326\/0003-4819-119-6-199309150-00010","article-title":"Empiric parenteral antibiotic treatment of patients with fibromyalgia and fatigue and a positive serologic result for Lyme disease: A cost- effectiveness analysis","volume":"119","author":"RW Lightfoot","year":"1993","journal-title":"Ann Intern Med"},{"key":"pone.0291382.ref084","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0002-9343(98)00112-0","article-title":"Detection of Borrelia burgdorferi DNA in muscle of patients with chronic myalgia related to lyme disease","volume":"104","author":"M Frey","year":"1998","journal-title":"Am J Med"},{"key":"pone.0291382.ref085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1573397117666210924152636","article-title":"Is Fibromyalgia Associated with Borrelia-specific T Lymphocytes?","volume":"18","author":"BK Puri","year":"2021","journal-title":"Curr Rheumatol Rev"},{"key":"pone.0291382.ref086","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10067-014-2706-z","article-title":"Characteristics of seroconversion and implications for diagnosis of post-treatment Lyme disease syndrome: acute and convalescent serology among a prospective cohort of early Lyme disease patients","volume":"34","author":"AW Rebman","year":"2014","journal-title":"Clin Rheumatol"},{"key":"pone.0291382.ref087","article-title":"A Critical Appraisal of \u201cChronic Lyme Disease","author":"HM Feder","year":"2007","journal-title":"N Engl J Med"},{"key":"pone.0291382.ref088","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cmi.2015.08.005","article-title":"Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about their aetiology","volume":"21","author":"M Markowicz","year":"2015","journal-title":"Clin Microbiol Infect"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0291382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T18:39:52Z","timestamp":1699468792000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0291382"}},"subtitle":[],"editor":[{"given":"Raquel","family":"Inocencio da Luz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":88,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0291382","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,8]]}}}